SCHEMBL29489261

SCHEMBL29489261

Cc1cccc(C(=O)OC(C)(C)C)c1OC(=O)OC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ HPGD P15428 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ ELANE P08246 1/20 0.41
▸ AR P10275 1/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ESR2 Q92731 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ POLB P06746 1/20 0.34
▸ ADRA1A P35348 1/20 0.34
▸ ADRA1B P35368 1/20 0.34
▸ PTPN1 P18031 1/20 0.33
▸ GRM6 O15303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15867195 1.00 KDM4E (0.47) KDM4EALDH1A1HPGDHSD17B10ELANE
SCHEMBL23628555 0.88 KDM4E (0.64) KDM4EALDH1A1HPGDHSD17B10ELANE
SCHEMBL2761277 0.87 ELANE (0.49) KDM4EALDH1A1HPGDHSD17B10ELANE
SCHEMBL31410748 0.85 ALDH1A1 (0.44) KDM4EALDH1A1HPGDHSD17B10AR
SCHEMBL29575324 0.80 ELANE (0.38) ALDH1A1ELANEARMEN1KMT2A
SCHEMBL15867197 0.80 ELANE (0.38) ALDH1A1ELANEARMEN1KMT2A
SCHEMBL27281232 0.79 ELANE (0.42) KDM4EALDH1A1HPGDHSD17B10ELANE
SCHEMBL18089663 0.79 NR1H2 (0.38) ELANEADRA1AADRA1B
SCHEMBL4352323 0.78 MEN1 (0.46) KDM4EALDH1A1HPGDHSD17B10AR
SCHEMBL7789873 0.78 ADRA1A (0.39) ALDH1A1HSD17B10ARMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11649222-B2 Compounds UNIVERSITETET I OSLO (NO) 2023-05-16 — — US disclosed
EP-3978488-A1 ZINC CHELATING COMPOUNDS FOR USE IN THE TREATMENT OF BACTERIAL INFECTION Universitetet I Oslo (NO) 2022-04-06 — — EP disclosed
CN-109952297-B Compound (I) 奥斯陆大学 2022-02-25 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11649222-B2 Compounds SLC30A6, SLC39A11, SLC39A3 KDM4E 2941/4885ALDH1A1 3235/4885HPGD 448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback